171 related articles for article (PubMed ID: 22404870)
1. An automatic wash method for dimethyl sulfoxide removal in autologous hematopoietic stem cell transplantation decreases the adverse effects related to infusion.
Sánchez-Salinas A; Cabañas-Perianes V; Blanquer M; Majado MJ; Insausti CL; Monserrat J; Sánchez-Ibáñez MV; Menchón P; García-Hernández A; Gómez-Espuch J; Morales A; Moraleda JM
Transfusion; 2012 Nov; 52(11):2382-6. PubMed ID: 22404870
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic engraftment of dimethyl sulfoxide-depleted autologous peripheral blood progenitor cells.
Akkök CA; Holte MR; Tangen JM; Ostenstad B; Bruserud O
Transfusion; 2009 Feb; 49(2):354-61. PubMed ID: 18980622
[TBL] [Abstract][Full Text] [Related]
3. Autologous peripheral blood progenitor cells cryopreserved with 5 and 10 percent dimethyl sulfoxide alone give comparable hematopoietic reconstitution after transplantation.
Akkök CA; Liseth K; Nesthus I; Løkeland T; Tefre K; Bruserud O; Abrahamsen JF
Transfusion; 2008 May; 48(5):877-83. PubMed ID: 18298599
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of an automated cell processing device to reduce the dimethyl sulfoxide from hematopoietic grafts after thawing.
Rodríguez L; Velasco B; García J; Martín-Henao GA
Transfusion; 2005 Aug; 45(8):1391-7. PubMed ID: 16078930
[TBL] [Abstract][Full Text] [Related]
5. Clinical experience with the delivery of thawed and washed autologous blood cells, with an automated closed fluid management device: CytoMate.
Lemarie C; Calmels B; Malenfant C; Arneodo V; Blaise D; Viret F; Bouabdallah R; Ladaique P; Viens P; Chabannon C
Transfusion; 2005 May; 45(5):737-42. PubMed ID: 15847663
[TBL] [Abstract][Full Text] [Related]
6. Preclinical evaluation of an automated closed fluid management device: Cytomate, for washing out DMSO from hematopoietic stem cell grafts after thawing.
Calmels B; Houzé P; Hengesse JC; Ducrot T; Malenfant C; Chabannon C
Bone Marrow Transplant; 2003 May; 31(9):823-8. PubMed ID: 12732892
[TBL] [Abstract][Full Text] [Related]
7. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells.
Ozdemir E; Akgedik K; Akdogan S; Kansu E
Biol Blood Marrow Transplant; 2008 Dec; 14(12):1425-8. PubMed ID: 19041066
[TBL] [Abstract][Full Text] [Related]
8. Washing transplants with Sepax 2 reduces the incidence of side effects associated with autologous transplantation and increases patients' comfort.
Huvarová L; Kořístek Z; Jelínek T; Černá L; Smejkalová J; Navrátil M; Grebeníček L; Tvrdá I; Michalíková M; Hájek R
Transfusion; 2021 Aug; 61(8):2430-2438. PubMed ID: 34197635
[TBL] [Abstract][Full Text] [Related]
9. The value of the post-thaw CD34+ count with and without DMSO removal in the setting of autologous stem cell transplantation.
Rohner N; Passweg JR; Tsakiris DA; Halter JP; Heim D; Buser AS; Infanti L; Holbro A
Transfusion; 2019 Mar; 59(3):1052-1060. PubMed ID: 30556582
[TBL] [Abstract][Full Text] [Related]
10. Clinical toxicity of cryopreserved circulating progenitor cells infusion.
Zambelli A; Poggi G; Da Prada G; Pedrazzoli P; Cuomo A; Miotti D; Perotti C; Preti P; Robustelli della Cuna G
Anticancer Res; 1998; 18(6B):4705-8. PubMed ID: 9891544
[TBL] [Abstract][Full Text] [Related]
11. Automatic washing of thawed haematopoietic progenitor cell grafts: a preclinical evaluation.
Abonnenc M; Pesse B; Tissot JD; Barelli S; Lion N
Vox Sang; 2017 May; 112(4):367-378. PubMed ID: 28337763
[TBL] [Abstract][Full Text] [Related]
12. Processing of hematopoietic stem cells from peripheral blood before cryopreservation: use of a closed automated system.
Zinno F; Landi F; Scerpa MC; Aureli V; Lanti A; Ceccarelli S; Caniglia M; Miele MJ; Daniele N; Landolfo A; Cometa AM; Locatelli F; Isacchi G
Transfusion; 2011 Dec; 51(12):2656-63. PubMed ID: 21599671
[TBL] [Abstract][Full Text] [Related]
13. Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide.
Morris C; de Wreede L; Scholten M; Brand R; van Biezen A; Sureda A; Dickmeiss E; Trneny M; Apperley J; Chiusolo P; van Imhoff GW; Lenhoff S; Martinelli G; Hentrich M; Pabst T; Onida F; Quinn M; Kroger N; de Witte T; Ruutu T;
Transfusion; 2014 Oct; 54(10):2514-22. PubMed ID: 24964911
[TBL] [Abstract][Full Text] [Related]
14. Use of different DMSO concentrations for cryopreservation of autologous peripheral blood stem cell grafts does not have any major impact on levels of leukocyte- and platelet-derived soluble mediators.
Akkök CA; Liseth K; Hervig T; Ryningen A; Bruserud Ø; Ersvaer E
Cytotherapy; 2009; 11(6):749-60. PubMed ID: 19878061
[TBL] [Abstract][Full Text] [Related]
15. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
16. Cell loss and recovery in umbilical cord blood processing: a comparison of postthaw and postwash samples.
Laroche V; McKenna DH; Moroff G; Schierman T; Kadidlo D; McCullough J
Transfusion; 2005 Dec; 45(12):1909-16. PubMed ID: 16371043
[TBL] [Abstract][Full Text] [Related]
17. Impact of different dimethyl sulphoxide concentrations on cell recovery, viability and clonogenic potential of cryopreserved peripheral blood hematopoietic stem and progenitor cells.
Smagur A; Mitrus I; Giebel S; Sadus-Wojciechowska M; Najda J; Kruzel T; Czerw T; Gliwinska J; Prokop M; Glowala-Kosinska M; Chwieduk A; Holowiecki J
Vox Sang; 2013 Apr; 104(3):240-7. PubMed ID: 23046417
[TBL] [Abstract][Full Text] [Related]
18. Autologous CD34+ cell transplantation for patients with advanced lymphoma: effects of overnight storage on peripheral blood progenitor cell enrichment and engraftment.
Koç ON; Gerson SL; Phillips GL; Cooper BW; Kutteh L; Van Zant G; Reece DE; Fox RM; Schupp JE; Tainer N; Lazarus HM
Bone Marrow Transplant; 1998 Feb; 21(4):337-43. PubMed ID: 9509966
[TBL] [Abstract][Full Text] [Related]
19. Occurrence and severity of adverse events after autologous hematopoietic progenitor cell infusion are related to the amount of granulocytes in the apheresis product.
Calmels B; Lemarié C; Esterni B; Malugani C; Charbonnier A; Coso D; de Colella JM; Deconinck E; Caillot D; Viret F; Ladaique P; Lapierre V; Chabannon C
Transfusion; 2007 Jul; 47(7):1268-75. PubMed ID: 17581163
[TBL] [Abstract][Full Text] [Related]
20. Comparison of time to engraftment between autologous patients receiving washed versus non-washed cryopreserved peripheral blood stem cell products.
Reich-Slotky R; Makhani SS; Vasovic LV; Pearse RN; Rossi A; Philips A; Cushing MM; Singh AD; van Besien K
Leuk Lymphoma; 2018 Dec; 59(12):2829-2835. PubMed ID: 29790808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
